Cargando…
Primary effusion lymphoma: current perspectives
Primary effusion lymphoma (PEL) is a rare and aggressive disease, affecting a unique population of patients who are often elderly or immunocompromised. PEL is associated with human herpesvirus type-8 infection and most commonly presents as malignant effusions of the body cavities. Patients diagnosed...
Autores principales: | Narkhede, Mayur, Arora, Shagun, Ujjani, Chaitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029609/ https://www.ncbi.nlm.nih.gov/pubmed/29988764 http://dx.doi.org/10.2147/OTT.S167392 |
Ejemplares similares
-
Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas
por: Kim, Yoonjung, et al.
Publicado: (2014) -
The clinical development of obinutuzumab for the treatment of follicular lymphoma
por: Ma, Barbara, et al.
Publicado: (2017) -
Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
por: Raychaudhuri, Ruben, et al.
Publicado: (2022) -
Primary Effusion Lymphoma: A Clinicopathologic Perspective
por: Gathers, Diamone A., et al.
Publicado: (2022) -
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
por: Lai, Catherine, et al.
Publicado: (2019)